- Report
- January 2026
- 180 Pages
Global
From €4092EUR$4,500USD£3,506GBP
- Report
- July 2025
- 182 Pages
Global
From €4092EUR$4,500USD£3,506GBP
- Report
- January 2026
- 318 Pages
Global
From €2274EUR$2,500USD£1,948GBP
- Report
- October 2025
- 160 Pages
Global
From €2874EUR$3,160USD£2,462GBP
€3592EUR$3,950USD£3,078GBP
- Report
- March 2026
- 104 Pages
Global
From €3500EUR$4,123USD£3,104GBP
- Training
- November 2026
- 3 Days
Global
€1932EUR$2,198USD£1,599GBP
€2294EUR$2,611USD£1,899GBP
- Training
- September 2026
- 2 Days
Global
€1207EUR$1,373USD£999GBP
€1448EUR$1,648USD£1,199GBP
- Report
- August 2025
- 84 Pages
United States
From €3183EUR$3,500USD£2,727GBP
- Report
- February 2026
- 160 Pages
Europe
From €3019EUR$3,320USD£2,587GBP
€3774EUR$4,150USD£3,234GBP
- Report
- May 2026
- 350 Pages
Global
From €3633EUR$3,995USD£3,113GBP
- Report
- May 2026
- 350 Pages
Global
From €3633EUR$3,995USD£3,113GBP
- Report
- May 2026
- 450 Pages
Global
From €3633EUR$3,995USD£3,113GBP
- Report
- May 2026
- 700 Pages
Global
From €4543EUR$4,995USD£3,892GBP
- Report
- May 2026
- 300 Pages
Global
From €3633EUR$3,995USD£3,113GBP
- Report
- May 2026
- 800 Pages
Global
From €4543EUR$4,995USD£3,892GBP
- Report
- May 2026
- 200 Pages
Global
From €3633EUR$3,995USD£3,113GBP
- Report
- May 2026
- 355 Pages
Global
From €5255EUR$5,980USD£4,350GBP
- Report
- May 2026
- 241 Pages
Global
From €5255EUR$5,980USD£4,350GBP
- Report
- April 2026
- 289 Pages
Global
From €5255EUR$5,980USD£4,350GBP
- Report
- January 2026
- 314 Pages
Global
From €5255EUR$5,980USD£4,350GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more